The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with ...

A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...

Ahead of an advisory committee meeting later this week, the FDA revealed that all studies for RSV vaccines in young children ...

Not providing some services in languages other than English is a violation of civil rights. It can also create public health ...

Along with holiday arrangements, changing seasons signal the need for another type of preparation: vaccination.

Analysts issued an Underperform rating for shares while reluanching coverage of large-cap U.S. pharma and biotech names.

Six products in late-stage development have the potential to launch by 2030. Credit: MargJohnsonVA via Shutterstock. · ...

Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and ...

The S&P 500 fell 0.3% on Tuesday, Dec. 10, as the cooldown from last week's record-setting rally continued ahead of key ...

MinterEllison has advised Moderna in relation to its new mRNA manufacturing facility – a facility described by the firm as ...

The Southern Hemisphere’s only mRNA manufacturing facility has opened in Victoria to ensure world-class mRNA vaccines and ...